• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗α4β7整合素抗体维多珠单抗治疗掌跖脓疱病的潜在疗效

Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis.

作者信息

Terui Hitoshi, Moroi Rintaro, Masamune Atsushi, Aiba Setsuya, Yamasaki Kenshi

机构信息

Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

Case Rep Dermatol. 2023 Jan 27;15(1):22-25. doi: 10.1159/000529080. eCollection 2023 Jan-Apr.

DOI:10.1159/000529080
PMID:36726801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9885181/
Abstract

Palmoplantar pustulosis (PPP) is a chronic skin inflammatory disease in which blisters and pustules repeatedly develop on palms and soles. PPP is often refractory to topical therapy, oral therapy, phototherapy, and biologics that are usually applied for PPP. We report a patient with PPP improved by vedolizumab (anti-α4β7 integrin antibody) treatment for ulcerative colitis, suggesting the possibility of a new molecular target for PPP therapy.

摘要

掌跖脓疱病(PPP)是一种慢性皮肤炎症性疾病,手掌和脚底反复出现水疱和脓疱。PPP通常对常用于治疗该病的局部治疗、口服治疗、光疗和生物制剂治疗效果不佳。我们报告了一名患有PPP的患者,其溃疡性结肠炎经维多珠单抗(抗α4β7整合素抗体)治疗后病情改善,这提示了PPP治疗新分子靶点的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14d/9885181/b4b0bb4ba0fd/cde-2023-0015-0001-529080_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14d/9885181/b4b0bb4ba0fd/cde-2023-0015-0001-529080_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14d/9885181/b4b0bb4ba0fd/cde-2023-0015-0001-529080_F1.jpg

相似文献

1
Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis.抗α4β7整合素抗体维多珠单抗治疗掌跖脓疱病的潜在疗效
Case Rep Dermatol. 2023 Jan 27;15(1):22-25. doi: 10.1159/000529080. eCollection 2023 Jan-Apr.
2
Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.古塞库单抗治疗掌跖脓疱病:日本视角
Clin Pharmacol. 2021 Jun 23;13:135-143. doi: 10.2147/CPAA.S266223. eCollection 2021.
3
Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations.掌跖脓疱病(PPP)患者的诊断、筛查与治疗:当前实践与建议综述
Clin Cosmet Investig Dermatol. 2020 Aug 14;13:561-578. doi: 10.2147/CCID.S240607. eCollection 2020.
4
Photodynamic therapy for palmoplantar pustulosis: A case report.光动力疗法治疗掌跖脓疱病:病例报告。
Photodiagnosis Photodyn Ther. 2023 Dec;44:103829. doi: 10.1016/j.pdpdt.2023.103829. Epub 2023 Oct 6.
5
Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series.用JAK抑制剂托法替布成功治疗难治性掌跖脓疱病:病例系列
Infect Drug Resist. 2023 Aug 9;16:5165-5172. doi: 10.2147/IDR.S421299. eCollection 2023.
6
Involvement of Molecular Mechanisms between T/B Cells and IL-23: From Palmoplantar Pustulosis to Autoimmune Diseases.T/B 细胞与白细胞介素-23 之间分子机制的参与:从掌跖脓疱病到自身免疫性疾病。
Int J Mol Sci. 2022 Jul 27;23(15):8261. doi: 10.3390/ijms23158261.
7
An update on therapeutic options for palmoplantar pustulosis: a narrative review and expert recommendations.掌跖脓疱病治疗选择的最新进展:叙述性综述和专家建议。
Expert Rev Clin Immunol. 2023 May;19(5):499-516. doi: 10.1080/1744666X.2023.2185775. Epub 2023 Mar 27.
8
Interventions for chronic palmoplantar pustulosis.慢性掌跖脓疱病的干预措施。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD001433. doi: 10.1002/14651858.CD001433.pub2.
9
Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.掌跖脓疱病:对疾病定义和发病机制的当前认识
J Dermatol Sci. 2020 Apr;98(1):13-19. doi: 10.1016/j.jdermsci.2020.03.003. Epub 2020 Mar 14.
10
The microbiome of the "sterile" pustules in palmoplantar pustulosis.掌跖脓疱病“无菌”脓疱的微生物组。
Exp Dermatol. 2018 Dec;27(12):1372-1377. doi: 10.1111/exd.13791.

引用本文的文献

1
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies.掌跖脓疱病:风险因素与治疗的系统评价
Psoriasis (Auckl). 2023 Sep 22;13:33-58. doi: 10.2147/PTT.S400402. eCollection 2023.
2
An Assessment of Comparative Medication Durability in Inflammatory Bowel Disease Patients With and Without Co-morbid Psoriasis, Rheumatoid Arthritis, and/or Enteropathic Arthritis.评估伴有或不伴有合并症银屑病、类风湿关节炎和/或肠病性关节炎的炎症性肠病患者的比较药物持久性。
Dig Dis Sci. 2023 Oct;68(10):4001-4008. doi: 10.1007/s10620-023-08062-5. Epub 2023 Aug 9.

本文引用的文献

1
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus-Preliminary Data.斑块状银屑病和发疹性扁平苔藓患者循环中黏膜地址素细胞黏附分子-1和整合素β7——初步数据
Biology (Basel). 2021 Nov 3;10(11):1129. doi: 10.3390/biology10111129.
2
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?上皮屏障假说能否解释过敏、自身免疫和其他慢性疾病的增加?
Nat Rev Immunol. 2021 Nov;21(11):739-751. doi: 10.1038/s41577-021-00538-7. Epub 2021 Apr 12.
3
Similarity and difference between palmoplantar pustulosis and pustular psoriasis.
掌跖脓疱病与脓疱型银屑病的异同。
J Dermatol. 2021 Jun;48(6):750-760. doi: 10.1111/1346-8138.15826. Epub 2021 Mar 2.
4
Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial.古塞奇尤单抗(一种抗白细胞介素 23 单克隆抗体)治疗掌跖脓疱病的疗效和安全性:一项随机临床试验。
JAMA Dermatol. 2018 Mar 1;154(3):309-316. doi: 10.1001/jamadermatol.2017.5937.
5
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.抗 TNF 药物治疗炎症性肠病过程中诱导的矛盾性炎症。
Nat Rev Gastroenterol Hepatol. 2012 Sep;9(9):496-503. doi: 10.1038/nrgastro.2012.125. Epub 2012 Jul 3.
6
Up-regulation of ß1 integrin on tonsillar T cells and its induction by in vitro stimulation with α-streptococci in patients with pustulosis Palmaris et Plantaris.掌跖脓疱病患者扁桃体 T 细胞上 β1 整联蛋白的上调及其体外α-链球菌刺激诱导
J Clin Immunol. 2010 Nov;30(6):861-71. doi: 10.1007/s10875-010-9451-0. Epub 2010 Aug 17.
7
Distinct but overlapping epitopes are involved in alpha 4 beta 7-mediated adhesion to vascular cell adhesion molecule-1, mucosal addressin-1, fibronectin, and lymphocyte aggregation.不同但相互重叠的表位参与α4β7介导的与血管细胞黏附分子-1、黏膜定居素-1、纤连蛋白的黏附以及淋巴细胞聚集。
J Immunol. 1994 Nov 1;153(9):3847-61.